Hydrocodone and Reyataz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydrocodone (hydrocodone bitartrate; ibuprofen) and Reyataz (atazanavir sulfate). Common drug interactions include blood creatinine increased among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Hydrocodone and Reyataz. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Hydrocodone?

Hydrocodone has active ingredients of hydrocodone bitartrate; ibuprofen. eHealthMe is studying from 13,115 Hydrocodone users. Check the latest studies of Hydrocodone.

What is Reyataz?

Reyataz has active ingredients of atazanavir sulfate. It is often used in hiv infection. eHealthMe is studying from 11,386 Reyataz users. Check the latest studies of Reyataz.



On Jul, 19, 2026

56 people who take Hydrocodone and Reyataz together, and have interactions are studied.

Hydrocodone and Reyataz drug interactions.

What are the common drug interactions of Hydrocodone and Reyataz, by gender? *:

female:

  1. Blood creatinine increased
  2. Blood potassium decreased
  3. Enamel anomaly
  4. Glomerular filtration rate decreased
  5. Hip fracture
  6. Hypertension (high blood pressure)
  7. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  8. Lower limb fracture
  9. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  10. Nephropathy (damage to or disease of a kidney)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Renal failure (kidney dysfunction)
  4. Renal impairment (severely reduced kidney function)
  5. Back pain
  6. Dysstasia (difficulty in standing)
  7. Fatigue (feeling of tiredness)
  8. Spinal compression fracture (fracture due to spinal compression on bone)
  9. Asthenia (weakness)
  10. Insomnia (sleeplessness)

What are the common drug interactions of Hydrocodone and Reyataz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Emotional distress
  5. Pain
  6. Renal failure (kidney dysfunction)
  7. Depression
  8. Insomnia (sleeplessness)
  9. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  10. Renal injury (kidney injury)

40-49:

  1. Pain
  2. Bone density decreased
  3. Renal failure (kidney dysfunction)
  4. Anaemia (lack of blood)
  5. Depression
  6. Osteoporosis (bones weak and more likely to break)
  7. Renal impairment (severely reduced kidney function)
  8. Ankle fracture
  9. Hyperkalaemia (damage to or disease of the kidney)
  10. Hypertension (high blood pressure)

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Osteoporosis (bones weak and more likely to break)
  7. Bone density decreased
  8. Gait disturbance
  9. Chronic kidney disease
  10. Depression

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Insomnia (sleeplessness)
  5. Nephrolithiasis (calculi in the kidneys)
  6. Renal impairment (severely reduced kidney function)
  7. Tendon rupture (tear of tendon)
  8. Upper limb fracture
  9. Bone loss
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

What are the existing conditions these people have? *

  1. Pain: 10 people, 17.86%
  2. Stress And Anxiety: 7 people, 12.50%
  3. Bacterial Infection: 7 people, 12.50%
  4. High Blood Pressure: 7 people, 12.50%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 12.50%
  6. Nausea (feeling of having an urge to vomit): 6 people, 10.71%
  7. Depression: 6 people, 10.71%
  8. Inflammation: 5 people, 8.93%
  9. Fungal Infection: 5 people, 8.93%
  10. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Hydrocodone and Reyataz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hydrocodone and Reyataz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hydrocodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Reyataz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydrocodone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Reyataz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydrocodone bitartrate; ibuprofen and atazanavir sulfate (the active ingredients of Hydrocodone and Reyataz, respectively), and Hydrocodone and Reyataz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: